Several top Food and Drug Administration (FDA) officials, including Commissioner Robert Califf, admitted that Americans will now have to accept COVID-19 as another respiratory virus, comparing it to influenza. FDA Commissioner Robert Califf, Principal Deputy Commissioner Janet Woodcock, and top vaccine official Dr. Peterk Marks wrote for the Journal of the American Medical Association that COVID-19…
Facts Matter (May 6): Rare Blood Clotting Disorder from J&J Vaccine Cause FDA to Limit It’s Use
May 6, 2022
admin
blood clottingDaily UpdatesEpochTVFacts MatterFDAJohnson and Johnsonside effectsthrombocytopenia syndromeUSUS NewsVaccine
0 Comment
Over the past two years, people across this country were censored, suspended, and even banned from social media for questioning the potential side-effects of the vaccine. Many people were also fired from their workplace if they refused to take it. However, the FDA just released an official statement announcing that it will be severely restricting…
Facts Matter (May 6): Rare “Blood Clot Disorder” Causes FDA to Limit Use of J&J Vaccine Nationwide
May 6, 2022
admin
blood clottingDaily UpdatesEpochTVFacts MatterFDAJohnson and Johnsonside effectsthrombocytopenia syndromeUSUS NewsVaccine
0 Comment
Over the past two years, people across this country were censored, suspended, and even banned from social media for questioning the potential side-effects of the vaccine. Many people were also fired from their workplace if they refused to take it. However, the FDA just released an official statement announcing that it will be severely restricting…
FDA Restricts J&J’s COVID-19 Vaccine Over Risk of Blood Clots
The U.S. Food and Drug Administration (FDA) on Thursday announced it will restrict the use of the Johnson & Johnson COVID-19 vaccine to adults who cannot receive mRNA vaccines, due to the risk of potentially life-threatening side effects. The agency said the COVID-19 vaccine can now only be administered to people aged 18 years of age…
Biogen CEO to Step Down, Drugmaker Pulls Back on Alzheimer’s Drug Aduhelm
Biogen Inc said on Tuesday that Chief Executive Michel Vounatsos will step down and that the company is pulling back on selling its Alzheimer’s drug Aduhelm after the U.S. government’s Medicare program restricted coverage of the controversial treatment to patients in clinical trials. Vounatsos, who was named as the CEO in 2016, will continue in…
Capitol Report (May 3): Leaked Supreme Court Opinion Shocks Justice System
May 3, 2022
admin
abortionCapitol ReportChinaFDAfirearmFOXNews VideosPlanned ParenthoodRoe vs WadeSupreme CourtUSUS NewsWashington D.C.zoo
0 Comment
The landmark abortion ruling Roe v. Wade is on the cusp of being overturned. A leaked draft Supreme Court ruling shows how the Justices are expected to rule on an abortion case. Protestors have rallied in Washington to express their thoughts on the issue. Former Planned Parenthood clinic director Abby Johnson joins us to give…
FDA Declines to Approve 2 More China-Tested Drugs
The U.S. Food & Drug Administration (FDA) on Monday declined to approve two cancer treatment drugs developed by drugmakers who tested their products mainly in China. The federal agency’s rejection is a sign of an increasingly tough U.S stance on drugs being tested solely in China, after some drugmakers moved to save costs by conducting…
Federal Panel Recommends Against Using Ivermectin to Treat COVID-19
For the first time, a federal health panel recommended against the use of ivermectin for the treatment of COVID-19 despite reports that it has successfully been used to treat the virus. In a statement published last week, the National Institute of Health’s COVID-19 Treatment Guidelines Panel said that as the “safety and efficacy of ivermectin for…
Federal Panel Recommends Against Use of Ivermectin to Treat COVID-19
For the first time, a federal health panel has recommended against the use of ivermectin for the treatment of COVID-19, despite reports that it’s successfully been used to treat the illness. In a statement published last week, the National Institute of Health’s COVID-19 Treatment Guidelines Panel said that as the “safety and efficacy of ivermectin for…
Moderna Says Its Vaccine for Ages Under 6 Will Be Ready for US Review in June
WASHINGTON—Moderna Inc.’s chief medical officer said on Sunday the company’s vaccine for children under 6 years old will be ready for review by a Food and Drug Administration (FDA) panel when it meets in June. Moderna sought emergency use authorization from the FDA on Thursday. An advisory panel of experts to the U.S. drug regulator…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`